|
|
Latest Story |
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors |
GlobeNewswire |
Full Story → |
Headline News |
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women's Cancer |
4:01p ET March 18 '24 GlobeNewswire |
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights |
4:01p ET February 29 '24 GlobeNewswire |
PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference |
8:00a ET February 26 '24 GlobeNewswire |
More News → |
|
April 17 '24. Markets Closed. | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Previous data from yesterday, April 17 '24. |